PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.14%
Revenue growth 1.25-1.5x ADI's 10.58%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
13.66%
Gross profit growth 1.25-1.5x ADI's 10.87%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
17.15%
EBIT growth 75-90% of ADI's 21.36%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
17.15%
Operating income growth at 75-90% of ADI's 21.36%. Bill Ackman would demand a plan to enhance operating leverage.
20.87%
Net income growth comparable to ADI's 21.61%. Walter Schloss might see both following similar market or cost trajectories.
20.00%
EPS growth above 1.5x ADI's 12.50%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
20.00%
Diluted EPS growth above 1.5x ADI's 12.50%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.82%
Share count expansion well above ADI's 0.61%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.33%
Diluted share count expanding well above ADI's 0.61%. Michael Burry would fear significant dilution to existing owners' stakes.
-0.82%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
68.24%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
830.00%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
110.16%
10Y revenue/share CAGR above 1.5x ADI's 49.64%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
77.19%
Positive 5Y CAGR while ADI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
45.91%
Positive 3Y CAGR while ADI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
164.73%
Positive OCF/share growth while ADI is negative. John Neff might see a comparative advantage in operational cash viability.
147.97%
3Y OCF/share CAGR above 1.5x ADI's 67.49%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
1724.99%
10Y net income/share CAGR of 1724.99% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
2101.73%
5Y net income/share CAGR above 1.5x ADI's 203.38%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
224.85%
3Y net income/share CAGR 50-75% of ADI's 342.71%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
25.90%
Positive 5Y equity/share CAGR while ADI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
53.12%
Positive short-term equity growth while ADI is negative. John Neff sees a strong advantage in near-term net worth buildup.
47.43%
Dividend/share CAGR of 47.43% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-16.51%
Negative 5Y dividend/share CAGR while ADI stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-22.60%
Negative near-term dividend growth while ADI invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
16.65%
AR growth well above ADI's 5.01%. Michael Burry fears inflated revenue or higher default risk in the near future.
7.20%
Inventory growth well above ADI's 6.24%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
7.28%
Asset growth above 1.5x ADI's 4.75%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
7.82%
1.25-1.5x ADI's 5.35%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
0.24%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
0.94%
R&D dropping or stable vs. ADI's 9.90%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
17.41%
SG&A growth well above ADI's 4.35%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.